Considering the described pathophysiological mechanisms, our findings may carry relevant clinical implications: if confirmed in larger cohorts, the identification of specific CASR polymorphisms associated with distinct profiles could support a more personalized approach to the management of primary hyperparathyroidism, thus aiding clinicians in selecting patients who might benefit from targeted genetic testing. The gene discussed is CASR; the disease is primary hyperparathyroidism.